Skip to main navigation Skip to search Skip to main content

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ENERGIZE)

Project: Research

Project Details

StatusFinished
Effective start/end date04/3/18 → 07/17/20

Funding

  • AstraZeneca Pharmaceuticals LP: $20,706.64